The latest news from the global pharmaceutical industry. Below you will find news and information to keep you up-to-date with what is happening in your industry. Coverage includes regulatory approvals, recall announcements, mergers and acquisitions, personnel news and appointments, new facility and facility expansion updates, collaborations and agreements, and financial updates.
XOMA Corporation announced it has earned a $9 million milestone related to the U.S. Food and Drug Administration’s (FDA) approval of Day One ...
read more
Wednesday, April 24, 2024
Endo, Inc., a newly formed entity, announced that it has completed the previously announced acquisition of substantially all of the assets of Endo ...
read more
Wednesday, April 24, 2024
The vaccines market in terms of revenue was estimated to be worth $78.0 billion in 2024 and is poised to reach $94.9 billion by 2029, growing at a ...
read more
Wednesday, April 24, 2024
Harness Therapeutics, a biotechnology company focused on protein upregulation to develop next generation therapeutics for neurodegenerative diseases, ...
read more
Positive results from the LUNA 3 phase 3 study demonstrated that rilzabrutinib 400 mg twice daily orally achieved the primary endpoint of durable ...
read more
Abbvie Inc., Aspen Pharmacare Holdings Ltd and Aurobindo Pharma Ltd., and More to Emerge as Some of the Key Vendors
read more
Neurocrine Biosciences, Inc. (Nasdaq: NBIX), today announced positive topline data for its Phase 2 SAVITRI™ study. This randomized, double-blind, ...
read more
Endevica Bio, a company developing first-in-class peptide drug candidates, announced its novel weight-loss treatment was successful in a recent diet-...
read more
Amylyx Pharmaceuticals, Inc. announced the company has started a process with the U.S. FDA and Health Canada to voluntarily discontinue the marketing ...
read more
Asahi Kasei Bioprocess (AKB), part of the Asahi Kasei Group, and Axolabs have announced a strategic partnership in the burgeoning field of ...
read more
FAonline INC is voluntarily recalling all lots within expiry of the ForeverMen capsules to the consumer level. FDA analysis founds these products to ...
read more
Wednesday, April 10, 2024
Charles River Laboratories International, Inc. announced a plasmid DNA contract development and manufacturing organization (CDMO) collaboration with ...
read more
Wednesday, April 10, 2024
BrainStorm Cell Therapeutics Inc. , a developer of adult stem cell therapeutics for neurodegenerative diseases, announced that it received written ...
read more
Wednesday, April 10, 2024
Essential Pharma, a specialty pharma group has completed the acquisition of the entire issued share capital of Renaissance Pharma Ltd. Renaissance ...
read more
Wednesday, April 10, 2024
Ascend Advanced Therapies has acquired the CMC team and site in Alachua, Florida from Beacon Therapeutics. The transaction brings an operational good ...
read more